Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors

✍ Scribed by Sausville, Edward; LoRusso, Patricia; Carducci, Michael; Carter, Judith; Quinn, Mary F.; Malburg, Lisa; Azad, Nilofer; Cosgrove, David; Knight, Richard; Barker, Peter; Zabludoff, Sonya; Agbo, Felix; Oakes, Patricia; Senderowicz, Adrian

• Book ID: 121544942
• Publisher: Springer
• Year: 2014
• Tongue: English
• Weight: 560 KB
• Volume: 73
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-014-2380-5